Tumor suppression and inhibition of aneuploid cell accumulation in human brain tumor cells by ectopic overexpression of the cyclin-dependent kinase inhibitor p27(KIP1)

被引:76
|
作者
Chen, J [1 ]
Willingham, T [1 ]
Shuford, M [1 ]
Nisen, PD [1 ]
机构
[1] UNIV TEXAS,SW MED CTR,DEPT PEDIAT,DALLAS,TX 75230
来源
JOURNAL OF CLINICAL INVESTIGATION | 1996年 / 97卷 / 08期
关键词
gene therapy; adenovirus; cell cycle; aneuploidy; brain tumors;
D O I
10.1172/JCI118631
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
To investigate how overexpression of p27(KIP1), a downstream effector of TGF-beta and a universal cyclin-dependent kinase (CDK) inhibitor could influence the malignant phenotype of malignant human brain tumor cells, an adenovirus vector system was used to transfer the human p27(KIP1) gene (Adp27(KIP1)) into the human astrocytoma cell line, U-373MG. Inhibition of CDK activity in Adp27(KIP1)-infected cells was indicated by inhibition of [H-3]thymidine incorporation, an increase in cell doubling time and by cell cycle arrest in G(1). Notably, ectopic overexpression of p27(KIP1) was associated with a marked decrease in the accumulation of aneuploid cells. Diminished malignant potential of Adp27(KIP1)-infected cells was manifested by the loss of anchorage-independent growth in soft agar and by the inability to induce tumorgenesis in a xenograft model. These studies suggest that p27(KIP1) is a tumor suppressor gene and supports the use of Adp27(KIP1) for gene therapy of human brain tumors.
引用
收藏
页码:1983 / 1988
页数:6
相关论文
共 50 条
  • [1] Impact of the cyclin-dependent kinase inhibitor p27(Kip1) on resistance of tumor cells to anticancer agents
    StCroix, B
    Florenes, VA
    Rak, JW
    Flanagan, M
    Bhattacharya, N
    Slingerland, JM
    Kerbel, RS
    NATURE MEDICINE, 1996, 2 (11) : 1204 - 1210
  • [2] Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation
    Durand, B
    Gao, FB
    Raff, M
    EMBO JOURNAL, 1997, 16 (02): : 306 - 317
  • [3] Overexpression of cyclin E and cyclin-dependent kinase inhibitor (p27(Kip1)): Effect on cell cycle regulation in HeLa cells
    Kwon, TK
    Nordin, AA
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1997, 238 (02) : 534 - 538
  • [4] Cloning and characterization of rat p27(Kip1), a cyclin-dependent kinase inhibitor
    Nomura, H
    Sawada, Y
    Fujinaga, K
    Ohtaki, S
    GENE, 1997, 191 (02) : 211 - 218
  • [5] Phosphorylation-dependent degradation of the cyclin-dependent kinase inhibitor p27(Kip1)
    Vlach, J
    Hennecke, S
    Amati, B
    EMBO JOURNAL, 1997, 16 (17): : 5334 - 5344
  • [6] Characterization of the murine cyclin-dependent kinase inhibitor gene p27(Kip1)
    Kwon, TK
    Nagel, JE
    Buchholz, MA
    Nordin, AA
    GENE, 1996, 180 (1-2) : 113 - 120
  • [7] MOLECULAR ANALYSIS OF THE CYCLIN-DEPENDENT KINASE INHIBITOR GENE P27/KIP1 IN HUMAN MALIGNANCIES
    KAWAMATA, N
    MOROSETTI, R
    MILLER, CW
    PARK, D
    SPIRIN, KS
    NAKAMAKI, T
    TAKEUCHI, S
    HATTA, Y
    SIMPSON, J
    WILCZYNSKI, S
    LEE, YY
    BARTRAM, CR
    KOEFFLER, HP
    CANCER RESEARCH, 1995, 55 (11) : 2266 - 2269
  • [8] Upregulation of the cyclin-dependent kinase inhibitor p27(KIP1) in differentiating and postnatal RPE cells
    Defoe, DM
    Levine, EM
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U578 - U578
  • [9] Cyclin-dependent kinase inhibitor p27(KIP1) in lymphoid tissue - p27(KIP1) expression is inversely proportional to the proliferative index
    SanchezBeato, M
    Saez, AI
    MartinezMontero, JC
    Mateo, MS
    SanchezVerde, L
    Villuendas, R
    Troncone, G
    Piris, MA
    AMERICAN JOURNAL OF PATHOLOGY, 1997, 151 (01): : 151 - 160
  • [10] Mutational analysis of the human cyclin-dependent kinase inhibitor p27(kip1) in primary breast carcinomas
    Ferrando, AA
    Balbin, M
    Pendas, AM
    Vizoso, F
    Velasco, G
    LopezOtin, C
    HUMAN GENETICS, 1996, 97 (01) : 91 - 94